Huntington's disease: from pathology and genetics to potential therapiesSara Imarisio, David C. Rubinsztein, Jenny Carmichael et al.|Biochemical Journal|2008Cited by 412
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Paul Edison, Eleni Frangou et al.|Trials|2019Cited by 214
Consensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar AtaxiasAntoni Matilla‐Dueñas, Ivelisse Sánchez, Tetsuo Ashizawa et al.|The Cerebellum|2013Cited by 133
Evaluation of liraglutide in the treatment of Alzheimer's diseasePaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Alzheimer s & Dementia|2021Cited by 72
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?Grazia Daniela Femminella, Paul Edison, Nicholas R Livingston et al.|Alzheimer s Research & Therapy|2021Cited by 59